Henry Meds

Henry Meds

Telehealth weight-loss program with prescribed meds

Overview

Henry Meds delivers weight-loss programs through telehealth with licensed providers using a HIPAA-compliant platform called Doxy. Patients complete a medical history and receive a personalized plan that includes medication, delivered without injections or in-person visits. The program combines provider consultations and medication at transparent, upfront pricing with no hidden fees or long-term contracts, emphasizing easy access and affordability. The goal is to make effective weight loss accessible and convenient for a wide audience by offering remote care and included medications.

Significant Headcount Growth

About Henry Meds

Simplify's Rating
Why Henry Meds is rated
D+
Rated D+ on Competitive Edge
Rated D+ on Growth Potential
Rated D+ on Differentiation

Industries

Healthcare

Company Size

51-200

Company Stage

Seed

Total Funding

N/A

Headquarters

San Francisco, California

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Expands to low testosterone, perimenopause, and ED treatments.
  • Offers phentermine as affordable GLP-1 alternative with guidance.
  • Users lose ~18% body weight yearly on Semaglutide programs.

What critics are saying

  • FDA bans compounded Tirzepatide, eliminating 80% revenue now.
  • Hers steals share with 24/7 providers and nutrition trackers.
  • Novo Nordisk sells Wegovy directly at $299/month soon.

What makes Henry Meds unique

  • Henry Meds launches compounded oral dissolvable Tirzepatide tablets.
  • No subscriptions or hidden fees in transparent pricing model.
  • HIPAA-compliant Doxy enables audiovisual provider consultations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Unlimited Paid Time Off

Remote Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

8%

2 year growth

30%
Bakersfield.com
May 28th, 2024
Henry Meds Revolutionizes Weight Loss Treatment with Oral Tirzepatide Dissolvable Tablets

Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Henry Meds right now.

Find jobs on Simplify and start your career today

We update Henry Meds's jobs every few hours, so check again soon! Browse all jobs →